Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

por Amir, E, Broom, R, Freedman, O, Ooi, WS, Done, S, Gianfelice, D, Barth, D, Kahn, H, Clemons, M
Publicado 2009

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarker...

por Freedman, OC, Amir, E, Dranitsaris, G, Dowsett, M, Cole, DEC, Kahn, H, O'Malley, F, Verma, S, Clemons, M
Publicado 2009